IMDX

Insight Molecular Diagnostics

35 hedge funds and large institutions have $125M invested in Insight Molecular Diagnostics in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

1.2% more ownership

Funds ownership: 56.89%58.09% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
$1K
Net Calls
Net Calls Change

Top Buyers

1 +$436K
2 +$409K
3 +$245K
4
Jane Street
Jane Street
New York
+$240K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$225K

Top Sellers

1 -$148K
2 -$70.5K
3 -$67.2K
4
Renaissance Technologies
Renaissance Technologies
New York
-$57.6K
5
AIC
AWM Investment Company
New York
-$46.8K